Improved Adequacy of Levothyroxine Treatment in Low-Risk Differentiated Thyroid Cancer Using the 2025 ATA Criteria: A Multicenter Real-World Analysis of 1,016 Patients
{{output}}
Background: Levothyroxine titration is essential in low-risk differentiated thyroid cancer (DTC). Objective: To compare levothyroxine treatment... ...
